Horizon Pharma To Buy Vidara, Join Exodus To Ireland
Horizon Pharma (HZNP) followed many of its fellow drugmakers to Ireland Wednesday as it agreed to buy Dublin-based Vidara Therapeutics in a deal worth $660 million. Horizon shares jumped 17% in the stock market today, hitting an all-time high. Through a reverse merger, Horizon Pharma Inc. will turn into Horizon Pharma PLC, located in the low-tax haven of the Emerald Isle. Many specialty drugmakers have similarly bought their way there, including